A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma
Abstract Background and purpose To assess the effectiveness of radiotherapy in preventing tumour seeding after chest drain or pleural biopsy in patients with malignant mesothelioma and to determine, if tract metastases appear, whether they are tender or troublesome to patients. Patients and methods...
Saved in:
Published in | Radiotherapy and oncology Vol. 84; no. 1; pp. 18 - 22 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Ireland
Elsevier Ireland Ltd
01.07.2007
|
Subjects | |
Online Access | Get full text |
Cover
Loading…
Abstract | Abstract Background and purpose To assess the effectiveness of radiotherapy in preventing tumour seeding after chest drain or pleural biopsy in patients with malignant mesothelioma and to determine, if tract metastases appear, whether they are tender or troublesome to patients. Patients and methods Patients with a histological diagnosis of pleural mesothelioma and an invasive procedure within the preceding 21 days were stratified by age, performance status and treatment centre. Randomisation was performed between immediate drain site radiotherapy 21 Gy in three fractions (XRT arm) or best supportive care (BSC) with follow-up to 12 months. Patients were asked to complete questionnaires on treatment toxicity and on symptoms from any tract metastases detected. Results Sixty-one patients were recruited from two centres between 1998 and 2004; 56 men, 5 women, median age 70. 31 were allocated to drain site radiotherapy. Seven patients developed tract metastases associated with the drain site (four XRT arm, three BSC) and four developed metastases associated with subsequent procedures at other sites (three XRT, one BSC). Two patients each developed two tract metastases. Of the 12 metastases, nine overlay the previous drain site but three were adjacent to the site. No statistically significant difference was found in the risk of tract metastasis associated with the drain site between the arms ( p = 0.748). Conclusions Prophylactic drain site radiotherapy in malignant pleural mesothelioma does not reduce the incidence of tumour seeding by the margin indicated by previous studies. |
---|---|
AbstractList | To assess the effectiveness of radiotherapy in preventing tumour seeding after chest drain or pleural biopsy in patients with malignant mesothelioma and to determine, if tract metastases appear, whether they are tender or troublesome to patients.
Patients with a histological diagnosis of pleural mesothelioma and an invasive procedure within the preceding 21 days were stratified by age, performance status and treatment centre. Randomisation was performed between immediate drain site radiotherapy 21
Gy in three fractions (XRT arm) or best supportive care (BSC) with follow-up to 12 months. Patients were asked to complete questionnaires on treatment toxicity and on symptoms from any tract metastases detected.
Sixty-one patients were recruited from two centres between 1998 and 2004; 56 men, 5 women, median age 70. 31 were allocated to drain site radiotherapy. Seven patients developed tract metastases associated with the drain site (four XRT arm, three BSC) and four developed metastases associated with subsequent procedures at other sites (three XRT, one BSC). Two patients each developed two tract metastases. Of the 12 metastases, nine overlay the previous drain site but three were adjacent to the site. No statistically significant difference was found in the risk of tract metastasis associated with the drain site between the arms (
p
=
0.748).
Prophylactic drain site radiotherapy in malignant pleural mesothelioma does not reduce the incidence of tumour seeding by the margin indicated by previous studies. To assess the effectiveness of radiotherapy in preventing tumour seeding after chest drain or pleural biopsy in patients with malignant mesothelioma and to determine, if tract metastases appear, whether they are tender or troublesome to patients. Patients with a histological diagnosis of pleural mesothelioma and an invasive procedure within the preceding 21 days were stratified by age, performance status and treatment centre. Randomisation was performed between immediate drain site radiotherapy 21Gy in three fractions (XRT arm) or best supportive care (BSC) with follow-up to 12 months. Patients were asked to complete questionnaires on treatment toxicity and on symptoms from any tract metastases detected. Sixty-one patients were recruited from two centres between 1998 and 2004; 56 men, 5 women, median age 70. 31 were allocated to drain site radiotherapy. Seven patients developed tract metastases associated with the drain site (four XRT arm, three BSC) and four developed metastases associated with subsequent procedures at other sites (three XRT, one BSC). Two patients each developed two tract metastases. Of the 12 metastases, nine overlay the previous drain site but three were adjacent to the site. No statistically significant difference was found in the risk of tract metastasis associated with the drain site between the arms (p=0.748). Prophylactic drain site radiotherapy in malignant pleural mesothelioma does not reduce the incidence of tumour seeding by the margin indicated by previous studies. Abstract Background and purpose To assess the effectiveness of radiotherapy in preventing tumour seeding after chest drain or pleural biopsy in patients with malignant mesothelioma and to determine, if tract metastases appear, whether they are tender or troublesome to patients. Patients and methods Patients with a histological diagnosis of pleural mesothelioma and an invasive procedure within the preceding 21 days were stratified by age, performance status and treatment centre. Randomisation was performed between immediate drain site radiotherapy 21 Gy in three fractions (XRT arm) or best supportive care (BSC) with follow-up to 12 months. Patients were asked to complete questionnaires on treatment toxicity and on symptoms from any tract metastases detected. Results Sixty-one patients were recruited from two centres between 1998 and 2004; 56 men, 5 women, median age 70. 31 were allocated to drain site radiotherapy. Seven patients developed tract metastases associated with the drain site (four XRT arm, three BSC) and four developed metastases associated with subsequent procedures at other sites (three XRT, one BSC). Two patients each developed two tract metastases. Of the 12 metastases, nine overlay the previous drain site but three were adjacent to the site. No statistically significant difference was found in the risk of tract metastasis associated with the drain site between the arms ( p = 0.748). Conclusions Prophylactic drain site radiotherapy in malignant pleural mesothelioma does not reduce the incidence of tumour seeding by the margin indicated by previous studies. |
Author | McMenemin, Rhona Garcia, Jose Curto Hill, Jennifer O’Rourke, Noelle Paul, Jim Lawless, Claire |
Author_xml | – sequence: 1 fullname: O’Rourke, Noelle – sequence: 2 fullname: Garcia, Jose Curto – sequence: 3 fullname: Paul, Jim – sequence: 4 fullname: Lawless, Claire – sequence: 5 fullname: McMenemin, Rhona – sequence: 6 fullname: Hill, Jennifer |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/17588698$$D View this record in MEDLINE/PubMed |
BookMark | eNqFkV1LHTEQhkOx6NH6D0rZP7DrZL8SbwQRbQXBC-11yMekzWk2OSQ5wvn3zXKEQm-8SiDvM5l55pychBiQkK8UOgp0vtp2SZoYdNcDsA6mDvr-E9lQzq5b4JydkE2NsZbTEc7Iec5bAOhhYKfkjLKJ8_mab4i8bZIMJi4uo2l0DCVF7-u1JCd9E23jQsH0hqG4GJrsClbAuFh-Y5K7Q31uFundryBDaXYe96liC-Y14F1c5Bfy2Uqf8fL9vCA_H-5f7360T8_fH-9un1o90qm0I7WKq3HQHHDWI5-wr93PCkCNM7VsttYaOQ4TMFAalGKTVMpaPVCjh8EMF2Q81tUp5pzQil1yi0wHQUGsxsRWHI2J1ZiASVRjFft2xHZ7taD5B70rqoGbYwBr828Ok8jaYdBoXEJdhInuox_-L6C9C05L_wcPmLdxn0IVI6jIvQDxsm5tXVodFPo68PAXEVKYBA |
CitedBy_id | crossref_primary_10_1093_annonc_mdq471 crossref_primary_10_1007_s11864_023_01148_2 crossref_primary_10_1016_j_critrevonc_2016_05_004 crossref_primary_10_1007_s13665_012_0009_x crossref_primary_10_1200_JCO_18_01678 crossref_primary_10_1016_j_clon_2010_01_009 crossref_primary_10_1586_era_10_169 crossref_primary_10_1510_icvts_2010_256214 crossref_primary_10_1093_ejcts_ezaa158 crossref_primary_10_1111_j_1445_5994_2010_02223_x crossref_primary_10_1097_COC_0b013e3181d31f02 crossref_primary_10_12968_hmed_2015_76_7_384 crossref_primary_10_1007_s10269_016_2642_4 crossref_primary_10_1093_annonc_mdp134 crossref_primary_10_1097_JTO_0b013e3181f1cf2b crossref_primary_10_1016_S1877_1203_09_72519_4 crossref_primary_10_1016_j_lungcan_2018_07_007 crossref_primary_10_1111_j_1445_5994_2012_02925_x crossref_primary_10_1016_S1877_1203_10_70023_9 crossref_primary_10_1111_crj_12938 crossref_primary_10_1016_j_lungcan_2009_06_014 crossref_primary_10_1016_j_radonc_2017_08_003 crossref_primary_10_1016_j_rpor_2012_07_015 crossref_primary_10_1093_annonc_mdq173 crossref_primary_10_1111_j_1743_7563_2010_01319_x crossref_primary_10_1136_thoraxjnl_2017_211321 crossref_primary_10_1007_s15004_022_9127_y crossref_primary_10_1016_S0761_8425_08_82026_8 crossref_primary_10_1016_j_lungcan_2015_03_013 crossref_primary_10_26442_18151434_2020_4_200255 crossref_primary_10_1097_CCO_0b013e328324bc30 crossref_primary_10_1016_j_ejca_2011_05_012 crossref_primary_10_1016_j_jtcvs_2013_07_012 crossref_primary_10_1111_j_1759_7714_2010_00001_x crossref_primary_10_18093_0869_0189_2018_28_5_531_557 crossref_primary_10_5306_wjco_v12_i8_581 crossref_primary_10_1093_annonc_mdv199 crossref_primary_10_1007_s13665_013_0044_2 crossref_primary_10_1016_j_ctrv_2021_102265 crossref_primary_10_1016_S1470_2045_16_30387_4 crossref_primary_10_1183_13993003_00953_2019 crossref_primary_10_1097_MCP_0b013e3282fcea50 crossref_primary_10_1186_1750_1172_3_34 crossref_primary_10_1097_LBR_0000000000000100 crossref_primary_10_1016_j_lungcan_2007_12_022 crossref_primary_10_1016_j_ijrobp_2009_06_037 crossref_primary_10_1016_j_lungcan_2019_03_023 crossref_primary_10_1634_theoncologist_2010_0185 crossref_primary_10_1007_s00270_017_1583_7 crossref_primary_10_1002_14651858_CD012541 crossref_primary_10_1136_bmjopen_2015_010589 crossref_primary_10_1097_MCP_0b013e3282fe9a04 crossref_primary_10_2217_lmt_15_27 crossref_primary_10_1007_s11864_020_00807_y crossref_primary_10_1097_CPM_0b013e318235181f crossref_primary_10_1016_j_ctro_2018_09_004 crossref_primary_10_1080_17476348_2019_1627203 crossref_primary_10_1371_journal_pone_0190257 crossref_primary_10_1016_S1877_1203_19_30101_6 crossref_primary_10_1016_j_lungcan_2014_01_021 crossref_primary_10_1007_s00520_013_1753_3 crossref_primary_10_1016_S1877_1203_20_30095_1 crossref_primary_10_1111_1759_7714_12008 crossref_primary_10_1016_S1470_2045_16_30132_2 crossref_primary_10_1016_S1877_1203_22_00126_4 crossref_primary_10_1016_j_radonc_2011_08_038 crossref_primary_10_1200_JCO_2017_76_6394 crossref_primary_10_1378_chest_13_3057 crossref_primary_10_1136_bmjopen_2016_013324 crossref_primary_10_1016_j_canrad_2017_06_011 crossref_primary_10_1016_S1877_1203_18_30030_2 crossref_primary_10_2217_fon_09_7 crossref_primary_10_1016_j_ccm_2021_08_004 crossref_primary_10_1510_icvts_2011_267252 crossref_primary_10_1684_bdc_2013_1857 crossref_primary_10_3816_CLC_2009_n_005 crossref_primary_10_1378_chest_14_0872 crossref_primary_10_1016_j_rmr_2016_10_005 crossref_primary_10_18093_0869_0189_2010_3_11_29 crossref_primary_10_1517_14728210903074563 crossref_primary_10_1016_S1470_2045_16_30095_X crossref_primary_10_1053_j_ro_2013_03_017 crossref_primary_10_1016_j_jtho_2018_06_011 crossref_primary_10_1088_0031_9155_53_13_013 crossref_primary_10_1159_000494500 crossref_primary_10_1097_MCP_0000000000000385 crossref_primary_10_18093_0869_0189_2018_28_6_655_679 crossref_primary_10_1016_j_brachy_2009_08_009 crossref_primary_10_1111_j_1440_1843_2011_01948_x crossref_primary_10_1111_php_13065 crossref_primary_10_1200_JCO_2008_19_8523 crossref_primary_10_1183_16000617_0063_2016 crossref_primary_10_1016_j_critrevonc_2021_103278 crossref_primary_10_1136_bmjopen_2014_006673 crossref_primary_10_1016_j_pneumo_2012_12_003 crossref_primary_10_1016_S1877_1203_23_00151_9 crossref_primary_10_1016_j_ctrv_2012_11_004 crossref_primary_10_1186_s12885_015_1881_x crossref_primary_10_1016_S1470_2045_17_30459_X crossref_primary_10_1016_S1877_1203_21_00111_7 crossref_primary_10_1080_02841860701754182 crossref_primary_10_1186_s12890_016_0318_x crossref_primary_10_1016_j_critrevonc_2010_04_004 |
Cites_doi | 10.1016/S0936-6555(05)80540-0 10.1378/chest.108.3.754 10.1016/S0167-8140(03)00229-9 10.1038/sj.bjc.6601957 |
ContentType | Journal Article |
Copyright | Elsevier Ireland Ltd 2007 Elsevier Ireland Ltd |
Copyright_xml | – notice: Elsevier Ireland Ltd – notice: 2007 Elsevier Ireland Ltd |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION |
DOI | 10.1016/j.radonc.2007.05.022 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef |
DatabaseTitleList | MEDLINE |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
EISSN | 1879-0887 |
EndPage | 22 |
ExternalDocumentID | 10_1016_j_radonc_2007_05_022 17588698 S0167814007002435 1_s2_0_S0167814007002435 |
Genre | Clinical Trial, Phase III Randomized Controlled Trial Research Support, Non-U.S. Gov't Journal Article |
GroupedDBID | --- --K --M .1- .55 .FO .GJ .~1 0R~ 0SF 123 1B1 1P~ 1RT 1~. 1~5 29P 4.4 457 4G. 53G 5RE 5VS 7-5 71M 8P~ 9JM AABNK AACTN AAEDT AAEDW AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AAXKI AAXUO ABBQC ABFNM ABJNI ABMAC ABMZM ABOCM ABUDA ABXDB ACDAQ ACGFS ACIUM ACRLP ADBBV ADEZE ADMUD ADVLN AEBSH AEHWI AEKER AENEX AEVXI AFCTW AFJKZ AFKWA AFRHN AFTJW AFXIZ AGHFR AGUBO AGYEJ AHHHB AIEXJ AIKHN AITUG AJOXV AJRQY AJUYK AKRWK ALMA_UNASSIGNED_HOLDINGS AMFUW AMRAJ ANZVX ASPBG AVWKF AXJTR AZFZN BKOJK BLXMC BNPGV CS3 DU5 E3Z EBS EFJIC EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN G-2 G-Q GBLVA HED HMK HMO HVGLF HZ~ IHE J1W J5H KOM M27 M41 MO0 N9A NCXOZ O-L O9- OAUVE OC~ OO- OZT P-8 P-9 P2P PC. Q38 R2- RIG ROL RPZ SAE SDF SDG SEL SES SEW SPCBC SSH SSU SSZ T5K UV1 WUQ X7M Z5R ZGI ZXP ~G- AAIAV ABLVK ABYKQ AHPSJ AJBFU EFLBG LCYCR CGR CUY CVF ECM EIF NPM AAYXX CITATION |
ID | FETCH-LOGICAL-c415t-41fb8b43c80e6c485e21676b00b461f76fffda435070bc0bb75abbffc31dc33d3 |
IEDL.DBID | .~1 |
ISSN | 0167-8140 |
IngestDate | Thu Sep 26 17:36:56 EDT 2024 Sat Sep 28 07:46:46 EDT 2024 Fri Feb 23 02:32:46 EST 2024 Tue Oct 15 22:54:33 EDT 2024 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 1 |
Keywords | Prophylactic radiotherapy Mesothelioma Drain site |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c415t-41fb8b43c80e6c485e21676b00b461f76fffda435070bc0bb75abbffc31dc33d3 |
PMID | 17588698 |
PageCount | 5 |
ParticipantIDs | crossref_primary_10_1016_j_radonc_2007_05_022 pubmed_primary_17588698 elsevier_sciencedirect_doi_10_1016_j_radonc_2007_05_022 elsevier_clinicalkeyesjournals_1_s2_0_S0167814007002435 |
PublicationCentury | 2000 |
PublicationDate | 2007-07-01 |
PublicationDateYYYYMMDD | 2007-07-01 |
PublicationDate_xml | – month: 07 year: 2007 text: 2007-07-01 day: 01 |
PublicationDecade | 2000 |
PublicationPlace | Ireland |
PublicationPlace_xml | – name: Ireland |
PublicationTitle | Radiotherapy and oncology |
PublicationTitleAlternate | Radiother Oncol |
PublicationYear | 2007 |
Publisher | Elsevier Ireland Ltd |
Publisher_xml | – name: Elsevier Ireland Ltd |
References | Low, Khoury, Matthews (bib1) 1995; 7 De Ruysscher, Stotman (bib3) 2003; 68 Boutin, Rey, Viallat (bib2) 1995; 108 Bydder, Phillips, Joseph (bib4) 2004; 91 17978160 - Eur Respir J. 2007 Nov;30(5):1021 Bydder (10.1016/j.radonc.2007.05.022_bib4) 2004; 91 Boutin (10.1016/j.radonc.2007.05.022_bib2) 1995; 108 Low (10.1016/j.radonc.2007.05.022_bib1) 1995; 7 De Ruysscher (10.1016/j.radonc.2007.05.022_bib3) 2003; 68 |
References_xml | – volume: 68 start-page: 299 year: 2003 end-page: 302 ident: bib3 article-title: Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: a Dutch-Belgian survey publication-title: Radiother Oncol contributor: fullname: Stotman – volume: 108 start-page: 754 year: 1995 end-page: 758 ident: bib2 article-title: Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma publication-title: Chest contributor: fullname: Viallat – volume: 91 start-page: 9 year: 2004 end-page: 10 ident: bib4 article-title: A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma publication-title: Br J Cancer contributor: fullname: Joseph – volume: 7 start-page: 317 year: 1995 end-page: 318 ident: bib1 article-title: Prevention of tumour seeding following thoracoscopy in mesothelioma by prophylactic radiotherapy publication-title: Clin Oncol contributor: fullname: Matthews – volume: 7 start-page: 317 year: 1995 ident: 10.1016/j.radonc.2007.05.022_bib1 article-title: Prevention of tumour seeding following thoracoscopy in mesothelioma by prophylactic radiotherapy publication-title: Clin Oncol doi: 10.1016/S0936-6555(05)80540-0 contributor: fullname: Low – volume: 108 start-page: 754 year: 1995 ident: 10.1016/j.radonc.2007.05.022_bib2 article-title: Prevention of malignant seeding after invasive diagnostic procedures in patients with pleural mesothelioma publication-title: Chest doi: 10.1378/chest.108.3.754 contributor: fullname: Boutin – volume: 68 start-page: 299 year: 2003 ident: 10.1016/j.radonc.2007.05.022_bib3 article-title: Treatment of intervention sites of malignant pleural mesothelioma with radiotherapy: a Dutch-Belgian survey publication-title: Radiother Oncol doi: 10.1016/S0167-8140(03)00229-9 contributor: fullname: De Ruysscher – volume: 91 start-page: 9 year: 2004 ident: 10.1016/j.radonc.2007.05.022_bib4 article-title: A randomised trial of single-dose radiotherapy to prevent procedure tract metastasis by malignant mesothelioma publication-title: Br J Cancer doi: 10.1038/sj.bjc.6601957 contributor: fullname: Bydder |
SSID | ssj0002037 |
Score | 2.3170178 |
Snippet | Abstract Background and purpose To assess the effectiveness of radiotherapy in preventing tumour seeding after chest drain or pleural biopsy in patients with... To assess the effectiveness of radiotherapy in preventing tumour seeding after chest drain or pleural biopsy in patients with malignant mesothelioma and to... |
SourceID | crossref pubmed elsevier |
SourceType | Aggregation Database Index Database Publisher |
StartPage | 18 |
SubjectTerms | Aged Biopsy, Needle - adverse effects Catheterization - adverse effects Dose Fractionation Drain site Female Hematology, Oncology and Palliative Medicine Humans Male Mesothelioma Mesothelioma - pathology Mesothelioma - radiotherapy Middle Aged Neoplasm Seeding Pleura - pathology Pleural Neoplasms - pathology Pleural Neoplasms - radiotherapy Prophylactic radiotherapy Surveys and Questionnaires |
Title | A randomised controlled trial of intervention site radiotherapy in malignant pleural mesothelioma |
URI | https://www.clinicalkey.es/playcontent/1-s2.0-S0167814007002435 https://dx.doi.org/10.1016/j.radonc.2007.05.022 https://www.ncbi.nlm.nih.gov/pubmed/17588698 |
Volume | 84 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NS8MwGA4yQbyI386PkYPXuqRN03ocwzE_EXWwW2i-pLK1Y5sHL_5237QpTjwInhrapA1PkvdNmud9gtC5NjLlXPIgIxELmLWQMioOGA254opqqyq2xQMfjtjNOB6voX4TC-Nold721za9stb-Ttej2Z3leffZEeidXhN0Wier5wLNGbg_6NMXn980j5DUuplO39vlbsLnKo7XPNNl0QgZxhckDP9wTyu-Z7CNtvykEffqeu2gNVPsoo17vy2-h7IeBpejS2gzo7Fnn08gWZ3JgUuL8xVqI3YbxlBA5z766gMe4ylMyF8dKwbPJsZpceCpWbgMk7ycZvtoNLh66Q8Df3ZCoMAlLwFrK1PJIpUSwxVLYxMCAhwGmWSc2oRba3UGqAF6UhEpkziT0loVUa2iSEcHqFWUhTlCODGw6gGAs5AY5vTuTCgJtZSqyEiZ0TYKGsjErJbIEA137E3UELvTLhNBYgEQt1HS4Cqa8E8wWGbhR89CULEIBRG_Wni15I9OIsD-__HNw7oBv2sIC6WUX6bH_37nCdpsfvQSeopay_m7OYMZylJ2qi7YQeu9_tPdo7te3w4fvgCYMuh7 |
link.rule.ids | 315,783,787,4509,24128,27936,27937,45597,45691 |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV07T8MwELZKkYAF8X6DB9ZQO3GcMFYVqEDLApW6WfELBbVNRcvAwm_nnDhqEUMltiixE-vz-c6Ov_uM0LU2MuVc8iAjEQuYtXBlVBwwGnLFFdVWlWyLZ94dsMdhPGygTp0L42iV3vdXPr301v5Oy6PZmuZ568UR6J1eExitk9WL19A6c_NjMOqb7wXPIySVcKYT-HbF6_y5kuT1keliUisZxjckDFfEp6Xgc7-Dtv2sEberhu2ihpnsoY2-3xffR1kbQ8zRBXSa0djTz0dwWR7KgQuL8yVuI3Y7xlBB5z796gse4zHMyN8cLQZPR8aJceCxmbkCo7wYZwdocH_32ukG_vCEQEFMngPYVqaSRSolhiuWxiYEBDiMMsk4tQm31uoMYAP4pCJSJnEmpbUqolpFkY4OUXNSTMwxwomBZQ8gnIXEMCd4Z0JJqKVURUbKjJ6goIZMTCuNDFGTx95FBbE77jIRJBYA8QlKalxFnf8JHsvM_PCZCSpmoSDiTxcv1_xlJQICwIpvHlUduGghrJRSfpue_vudV2iz-9rvid7D89MZ2qr_-hJ6jprzj09zAdOVubwszfEHzo3ofw |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=A+randomised+controlled+trial+of+intervention+site+radiotherapy+in+malignant+pleural+mesothelioma&rft.jtitle=Radiotherapy+and+oncology&rft.au=O%E2%80%99Rourke%2C+Noelle&rft.au=Garcia%2C+Jose+Curto&rft.au=Paul%2C+Jim&rft.au=Lawless%2C+Claire&rft.date=2007-07-01&rft.pub=Elsevier+Ireland+Ltd&rft.issn=0167-8140&rft.eissn=1879-0887&rft.volume=84&rft.issue=1&rft.spage=18&rft.epage=22&rft_id=info:doi/10.1016%2Fj.radonc.2007.05.022&rft.externalDocID=S0167814007002435 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F01678140%2FS0167814007X80290%2Fcov150h.gif |